Compounds > zoledronic acid

Page last updated: 2024-08-25

zoledronic acid and Aging

zoledronic acid has been researched along with Aging in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (7.14)	29.6817
2010's	11 (78.57)	24.3611
2020's	2 (14.29)	2.80

Authors

Authors	Studies
Cabral, WA; Collins, FS; Cubria, MB; DuBose, A; Erdos, MR; Kamalapathy, P; Karim, L; Masoudi, A; Nazarian, A; Oftadeh, R; Snyder, BD; Suarez, S	1
Chen, S; Li, C; Li, H; Wang, R; Wang, Y; Yue, L	1
Babenko, NA; Storozhenko, GV	1
Babenko, NA; Hassouneh, LK; Timofiychuk, OA	1
Charlesworth, G; Daroszewska, A; Prior, A; Ralston, SH; Rose, K; Rose, L; Sarsam, N; van 't Hof, RJ	1
Casatti, CA; Cavazana, TP; de Almeida, JM; de Mello-Neto, JM; Dornelles, RCM; Ervolino, E; Garcia, VG; Issa, JPM; Nagata, MJH; Okamoto, R; Statkievicz, C; Theodoro, LH; Toro, LF	1
Biguetti, CC; Constantino, DH; Custódio, IDC; De Oliva, AH; Duarte, MAH; Ervolino, E; Fakhouri, WD; Healy, K; Mahmoud, RH; Matsumoto, MA	1
Jiang, K	1
Brennan, MA; Gleeson, JP; McNamara, LM; O'Brien, FJ	1
Bell, T; Bourque, WT; Daniels, T; Fetterly, CR; Harris, RL; Maurice, SB; Nelson, DR; Winwood, PJ	1
Gruntmanis, U; Piper, PK	1
Beck, FM; D'Atri, AM; Helm, NB; Huja, SS; Padala, S	1
Boucher, A; Räkel, A; Ste-Marie, LG	1
Anastasilakis, AD; Gkiomisi, A; Makras, P; Papatheodorou, A; Polyzos, SA; Savvides, M; Terpos, E	1

Reviews

2 review(s) available for zoledronic acid and Aging

Article	Year
Management of osteoporosis in the aging male: focus on zoledronic acid. Clinical interventions in aging, 2009, Volume: 4 Topics: Aged; Aged, 80 and over; Aging; Bone Density Conservation Agents; Diphosphonates; Fractures, Bone; Humans; Imidazoles; Male; Middle Aged; Osteoporosis; United States; Zoledronic Acid	2009
Role of zoledronic acid in the prevention and treatment of osteoporosis. Clinical interventions in aging, 2011, Volume: 6 Topics: Age Factors; Aging; Bone Density; Bone Density Conservation Agents; Clinical Trials as Topic; Diphosphonates; Fractures, Bone; Humans; Imidazoles; Injections, Intravenous; Osteoporosis; Osteoporosis, Postmenopausal; Risk Factors; Sex Factors; Zoledronic Acid	2011

Other Studies

12 other study(ies) available for zoledronic acid and Aging

Article	Year
Evaluation of musculoskeletal phenotype of the G608G progeria mouse model with lonafarnib, pravastatin, and zoledronic acid as treatment groups. Proceedings of the National Academy of Sciences of the United States of America, 2020, 06-02, Volume: 117, Issue:22 Topics: Aging; Animals; Bone and Bones; Bone Density Conservation Agents; Cartilage; Disease Models, Animal; Femur; Glycosaminoglycans; Joints; Lamin Type A; Mice; Mice, Transgenic; Mutation; Osteoarthritis; Phenotype; Piperidines; Pravastatin; Progeria; Protein Processing, Post-Translational; Pyridines; X-Ray Microtomography; Zoledronic Acid	2020
Effects of rosuvastatin and zoledronic acid in combination on the recovery of senile osteoporotic vertebral compression fracture following percutaneous vertebroplasty. The Journal of international medical research, 2020, Volume: 48, Issue:5 Topics: Age Factors; Aged; Aged, 80 and over; Aging; Bone Density; Case-Control Studies; Drug Therapy, Combination; Female; Fractures, Compression; Functional Status; Humans; Male; Middle Aged; Osteoporotic Fractures; Pain Management; Pain, Postoperative; Recurrence; Retrospective Studies; Rosuvastatin Calcium; Spinal Fractures; Treatment Outcome; Vertebroplasty; Zoledronic Acid	2020
[Role of ceramide in reduction of the cardiolipin content in the heart during aging]. Advances in gerontology = Uspekhi gerontologii, 2017, Volume: 30, Issue:1 Topics: Age Factors; Aging; Animals; Cardiolipins; Ceramides; Diphosphonates; Doxorubicin; Heart; Imidazoles; Imipramine; Male; Myocardium; Phosphatidic Acids; Rats; Rats, Wistar; Sphingomyelin Phosphodiesterase; Topoisomerase II Inhibitors; Zoledronic Acid	2017
Acid sphingomyelinase inhibitors, imipramine and zoledronic acid, increase skeletal muscle tissue sensitivity to insulin action at old age. General physiology and biophysics, 2018, Volume: 37, Issue:2 Topics: Aging; Animals; Ceramides; Diphosphonates; Imidazoles; Imipramine; Insulin; Male; Muscle, Skeletal; Rats; Rats, Wistar; Sphingomyelin Phosphodiesterase; Zoledronic Acid	2018
Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62 Disease models & mechanisms, 2018, 08-23, Volume: 11, Issue:9 Topics: Aging; Animals; Bone and Bones; Bone Resorption; Calcification, Physiologic; Disease Models, Animal; Mice, Inbred C57BL; Mice, Mutant Strains; Mutation; Organ Size; Osteitis Deformans; Osteoclasts; Phenotype; Sequestosome-1 Protein; Zoledronic Acid	2018
Antimicrobial photodynamic therapy improves the alveolar repair process and prevents the occurrence of osteonecrosis of the jaws after tooth extraction in senile rats treated with zoledronate. Bone, 2019, Volume: 120 Topics: Aging; Alveolar Process; Animals; Anti-Infective Agents; Bisphosphonate-Associated Osteonecrosis of the Jaw; Collagen; Female; Interleukin-1beta; Interleukin-6; Mouth Mucosa; Osteogenesis; Photochemotherapy; Rats, Wistar; Tartrate-Resistant Acid Phosphatase; Tooth Extraction; Tumor Necrosis Factor-alpha; Wound Healing; Zoledronic Acid	2019
Medication-related osteonecrosis of the jaws after tooth extraction in senescent female mice treated with zoledronic acid: Microtomographic, histological and immunohistochemical characterization. PloS one, 2019, Volume: 14, Issue:6 Topics: Aging; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Calcification, Physiologic; Collagen; Core Binding Factor Alpha 1 Subunit; Disease Models, Animal; Female; Mice; Tooth Extraction; Transforming Growth Factor beta; X-Ray Microtomography; Zoledronic Acid	2019
Drug development for progeria yields insights into normal aging. Nature medicine, 2013, Volume: 19, Issue:5 Topics: Aging; Child; Clinical Trials as Topic; Diphosphonates; Drug Discovery; Humans; Imidazoles; Lamin Type A; Mutation; Piperidines; Pravastatin; Progeria; Pyridines; Time Factors; Zoledronic Acid	2013
Effects of ageing, prolonged estrogen deficiency and zoledronate on bone tissue mineral distribution. Journal of the mechanical behavior of biomedical materials, 2014, Volume: 29 Topics: Aging; Animals; Bone Density; Bone Density Conservation Agents; Calcification, Physiologic; Diphosphonates; Estrogens; Femur; Imidazoles; Sheep; Time Factors; Zoledronic Acid	2014
Tibial bone versican content decreases with zoledronate treatment in adult mice. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2014, Volume: 25, Issue:7 Topics: Aggrecans; Aging; Animals; Bone Density Conservation Agents; Bone Remodeling; Diphosphonates; Female; Imidazoles; Mice, Inbred C57BL; Tibia; Versicans; Zoledronic Acid	2014
Short-term zoledronic acid reduces trabecular bone remodeling in dogs. European journal of oral sciences, 2010, Volume: 118, Issue:5 Topics: Aging; Animals; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Diphosphonates; Dogs; Imidazoles; Lumbar Vertebrae; Male; Mandibular Condyle; Zoledronic Acid	2010
Circulating activin-A is elevated in postmenopausal women with low bone mass: the three-month effect of zoledronic acid treatment. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2013, Volume: 24, Issue:7 Topics: Activins; Age Factors; Aged; Aging; Biomarkers; Bone Density; Bone Density Conservation Agents; Case-Control Studies; Diphosphonates; Female; Femur Neck; Humans; Imidazoles; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Zoledronic Acid	2013